Onderneming Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Aandelen
T14
CNE100000924
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,42 USD | -2,42% |
|
-6,56% | +16,91% |
15/05 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited kondigt bestuurs- en comitéwijzigingen aan | CI |
30/04 | Tianjin Pharmaceutical's Q1 Winst, Inkomsten dalen met 3% | MT |
Vakgebied
Aantal werknemers: 4 619
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Chinese Patent Medicine
71,0
%
| 5 652 | 68,5 % | 5 836 | 71,0 % | +3,26% |
Western Medicine
20,6
%
| 1 783 | 21,6 % | 1 697 | 20,6 % | -4,84% |
Other
8,2
%
| 796 | 9,7 % | 673 | 8,2 % | -15,47% |
Other Business
0,2
%
| 18 | 0,2 % | 16 | 0,2 % | -9,16% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,5
%
| 8 198 | 99,6 % | 8 161 | 99,5 % | -0,44% |
Overseas
0,5
%
| 34 | 0,4 % | 45 | 0,5 % | +33,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-22 |
Jian Ma
DFI | Director of Finance/CFO | 46 | 21-07-23 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-12-12 |
Ming Jie Shang
BRD | Director/Board Member | 55 | 01-03-23 |
42 | - | ||
54 | - | ||
Jian Wang
IRC | Investor Relations Contact | - | - |
51 | - | ||
- | - | ||
61 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 30-09-19 |
Guat Kwang Yeo
BRD | Director/Board Member | 63 | 28/11 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 05-06-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-12-12 |
Jian Hua Xing
BRD | Director/Board Member | 53 | 10-12-21 |
Mai Wang
BRD | Director/Board Member | 54 | 01-08-17 |
Xiu Mei Guo
BRD | Director/Board Member | 42 | 24-12-18 |
Yuan Xi Wang
CHM | Chairman | 46 | 02-12-19 |
Wei Wen Mao
BRD | Director/Board Member | 50 | 30-12-22 |
Ming Jie Shang
BRD | Director/Board Member | 55 | 01-03-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 200 000 000 | 0 | 0 | 31,14 % |
Aandeel B | 1 | 570 158 276 | 239 803 030 ( 42,06 %) | 1 285 200 ( 0,2254 %) |
Bedrijfsgegevens
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
No. 17 Baidi Road Nankai District
300193, Tianjin
+
http://en.pharm.com.cn![Adres Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(T14)](https://cdn.zonebourse.com/static/address/11551617.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,14% | 5,82 mld. | |
-30,04% | 3,65 mld. | |
-22,68% | 2,68 mld. | |
-8,17% | 2,31 mld. | |
+42,02% | 1,86 mld. | |
+45,22% | 1,45 mld. | |
-12,58% | 1,44 mld. | |
-27,42% | 1,36 mld. | |
+40,95% | 1,35 mld. |
- Beurs
- Aandelen
- Koers 600329
- Koers T14
- Onderneming Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited